[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |
Advanced search

Global Non-alcoholic Fatty Liver Disease (NAFLD) Drug Market Professional Survey Report 2016

September 2016 | 119 pages | ID: GDC2BA08822EN
QYResearch

US$ 3,500.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
Notes:

Production, means the output of Non-alcoholic Fatty Liver Disease (NAFLD) Drug

Revenue, means the sales value of Non-alcoholic Fatty Liver Disease (NAFLD) Drug

This report studies Non-alcoholic Fatty Liver Disease (NAFLD) Drug in Global market, especially in North America, Europe, China, Japan, Southeast Asia and India, with production, revenue, consumption, import and export in these regions, from 2011 to 2015, and forecast to 2021.

This report focuses on top manufacturers in global market, with production, price, revenue and market share for each manufacturer, covering
  • Conatus Pharmaceuticals
  • Daewoong Pharmaceutical
  • Galmed International
  • Kyorin Pharmaceutical
  • Metabolic Solutions Development
  • Novartis AG
  • Phenex Pharmaceuticals
  • Raptor Pharmaceuticals
  • TCM Biotech International
  • Tobira Therapeutics
  • Verva Pharmaceuticals
  • Zafgen
By types, the market can be split into
  • Type I
  • Type II
  • Type III
By Application, the market can be split into
  • Application 1
  • Application 2
  • Application 3
By Regions, this report covers (we can add the regions/countries as you want)
  • North America
  • China
  • Europe
  • Southeast Asia
  • Japan
  • India
Global Non-alcoholic Fatty Liver Disease (NAFLD) Drug Market Professional Survey Report 2016

1 INDUSTRY OVERVIEW OF NON-ALCOHOLIC FATTY LIVER DISEASE (NAFLD) DRUG

1.1 Definition and Specifications of Non-alcoholic Fatty Liver Disease (NAFLD) Drug
  1.1.1 Definition of Non-alcoholic Fatty Liver Disease (NAFLD) Drug
  1.1.2 Specifications of Non-alcoholic Fatty Liver Disease (NAFLD) Drug
1.2 Classification of Non-alcoholic Fatty Liver Disease (NAFLD) Drug
  1.2.1 Type I
  1.2.2 Type II
  1.2.3 Type III
1.3 Applications of Non-alcoholic Fatty Liver Disease (NAFLD) Drug
  1.3.1 Application
  1.3.2 Application
  1.3.3 Application
1.4 Market Segment by Regions
  1.4.1 North America
  1.4.2 China
  1.4.3 Europe
  1.4.4 Southeast Asia
  1.4.5 Japan
  1.4.6 India

2 MANUFACTURING COST STRUCTURE ANALYSIS OF NON-ALCOHOLIC FATTY LIVER DISEASE (NAFLD) DRUG

2.1 Raw Material and Suppliers
2.2 Manufacturing Cost Structure Analysis of Non-alcoholic Fatty Liver Disease (NAFLD) Drug
2.3 Manufacturing Process Analysis of Non-alcoholic Fatty Liver Disease (NAFLD) Drug
2.4 Industry Chain Structure of Non-alcoholic Fatty Liver Disease (NAFLD) Drug

3 TECHNICAL DATA AND MANUFACTURING PLANTS ANALYSIS OF NON-ALCOHOLIC FATTY LIVER DISEASE (NAFLD) DRUG

3.1 Capacity and Commercial Production Date of Global Non-alcoholic Fatty Liver Disease (NAFLD) Drug Major Manufacturers in 2015
3.2 Manufacturing Plants Distribution of Global Non-alcoholic Fatty Liver Disease (NAFLD) Drug Major Manufacturers in 2015
3.3 R&D Status and Technology Source of Global Non-alcoholic Fatty Liver Disease (NAFLD) Drug Major Manufacturers in 2015
3.4 Raw Materials Sources Analysis of Global Non-alcoholic Fatty Liver Disease (NAFLD) Drug Major Manufacturers in 2015

4 GLOBAL NON-ALCOHOLIC FATTY LIVER DISEASE (NAFLD) DRUG OVERALL MARKET OVERVIEW

4.1 2011-2016E Overall Market Analysis
4.2 Capacity Analysis
  4.2.1 2011-2016E Global Non-alcoholic Fatty Liver Disease (NAFLD) Drug Capacity and Growth Rate Analysis
  4.2.2 2015 Non-alcoholic Fatty Liver Disease (NAFLD) Drug Capacity Analysis (Company Segment)
4.3 Sales Analysis
  4.3.1 2011-2016E Global Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales and Growth Rate Analysis
  4.3.2 2015 Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales Analysis (Company Segment)
4.4 Sales Price Analysis
  4.4.1 2011-2016E Global Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales Price
  4.4.2 2015 Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales Price Analysis (Company Segment)

5 NON-ALCOHOLIC FATTY LIVER DISEASE (NAFLD) DRUG REGIONAL MARKET ANALYSIS

5.1 North America Non-alcoholic Fatty Liver Disease (NAFLD) Drug Market Analysis
  5.1.1 North America Non-alcoholic Fatty Liver Disease (NAFLD) Drug Market Overview
  5.1.2 North America 2011-2016E Non-alcoholic Fatty Liver Disease (NAFLD) Drug Local Supply, Import, Export, Local Consumption Analysis
  5.1.3 North America 2011-2016E Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales Price Analysis
  5.1.4 North America 2015 Non-alcoholic Fatty Liver Disease (NAFLD) Drug Market Share Analysis
5.2 China Non-alcoholic Fatty Liver Disease (NAFLD) Drug Market Analysis
  5.2.1 China Non-alcoholic Fatty Liver Disease (NAFLD) Drug Market Overview
  5.2.2 China 2011-2016E Non-alcoholic Fatty Liver Disease (NAFLD) Drug Local Supply, Import, Export, Local Consumption Analysis
  5.2.3 China 2011-2016E Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales Price Analysis
  5.2.4 China 2015 Non-alcoholic Fatty Liver Disease (NAFLD) Drug Market Share Analysis
5.3 Europe Non-alcoholic Fatty Liver Disease (NAFLD) Drug Market Analysis
  5.3.1 Europe Non-alcoholic Fatty Liver Disease (NAFLD) Drug Market Overview
  5.3.2 Europe 2011-2016E Non-alcoholic Fatty Liver Disease (NAFLD) Drug Local Supply, Import, Export, Local Consumption Analysis
  5.3.3 Europe 2011-2016E Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales Price Analysis
  5.3.4 Europe 2015 Non-alcoholic Fatty Liver Disease (NAFLD) Drug Market Share Analysis
5.4 Southeast Asia Non-alcoholic Fatty Liver Disease (NAFLD) Drug Market Analysis
  5.4.1 Southeast Asia Non-alcoholic Fatty Liver Disease (NAFLD) Drug Market Overview
  5.4.2 Southeast Asia 2011-2016E Non-alcoholic Fatty Liver Disease (NAFLD) Drug Local Supply, Import, Export, Local Consumption Analysis
  5.4.3 Southeast Asia 2011-2016E Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales Price Analysis
  5.4.4 Southeast Asia 2015 Non-alcoholic Fatty Liver Disease (NAFLD) Drug Market Share Analysis
5.5 Japan Non-alcoholic Fatty Liver Disease (NAFLD) Drug Market Analysis
  5.5.1 Japan Non-alcoholic Fatty Liver Disease (NAFLD) Drug Market Overview
  5.5.2 Japan 2011-2016E Non-alcoholic Fatty Liver Disease (NAFLD) Drug Local Supply, Import, Export, Local Consumption Analysis
  5.5.3 Japan 2011-2016E Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales Price Analysis
  5.5.4 Japan 2015 Non-alcoholic Fatty Liver Disease (NAFLD) Drug Market Share Analysis
5.6 India Non-alcoholic Fatty Liver Disease (NAFLD) Drug Market Analysis
  5.6.1 India Non-alcoholic Fatty Liver Disease (NAFLD) Drug Market Overview
  5.6.2 India 2011-2016E Non-alcoholic Fatty Liver Disease (NAFLD) Drug Local Supply, Import, Export, Local Consumption Analysis
  5.6.3 India 2011-2016E Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales Price Analysis
  5.6.4 India 2015 Non-alcoholic Fatty Liver Disease (NAFLD) Drug Market Share Analysis

6 GLOBAL 2011-2016E NON-ALCOHOLIC FATTY LIVER DISEASE (NAFLD) DRUG SEGMENT MARKET ANALYSIS (BY TYPE)

6.1 Global 2011-2016E Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales by Type
6.2 Different Types of Non-alcoholic Fatty Liver Disease (NAFLD) Drug Product Interview Price Analysis
6.3 Different Types of Non-alcoholic Fatty Liver Disease (NAFLD) Drug Product Driving Factors Analysis
  6.3.1 Type I Non-alcoholic Fatty Liver Disease (NAFLD) Drug Growth Driving Factor Analysis
  6.3.2 Type II Non-alcoholic Fatty Liver Disease (NAFLD) Drug Growth Driving Factor Analysis
  6.3.3 Type III Non-alcoholic Fatty Liver Disease (NAFLD) Drug Growth Driving Factor Analysis

7 GLOBAL 2011-2016E NON-ALCOHOLIC FATTY LIVER DISEASE (NAFLD) DRUG SEGMENT MARKET ANALYSIS (BY APPLICATION)

7.1 Global 2011-2016E Non-alcoholic Fatty Liver Disease (NAFLD) Drug Consumption by Application
7.2 Different Application of Non-alcoholic Fatty Liver Disease (NAFLD) Drug Product Interview Price Analysis
7.3 Different Application of Non-alcoholic Fatty Liver Disease (NAFLD) Drug Product Driving Factors Analysis
  7.3.1 Application 1 Non-alcoholic Fatty Liver Disease (NAFLD) Drug Growth Driving Factor Analysis
  7.3.2 Application 2 Non-alcoholic Fatty Liver Disease (NAFLD) Drug Growth Driving Factor Analysis
  7.3.3 Application 3 Non-alcoholic Fatty Liver Disease (NAFLD) Drug Growth Driving Factor Analysis

8 MAJOR MANUFACTURERS ANALYSIS OF NON-ALCOHOLIC FATTY LIVER DISEASE (NAFLD) DRUG

8.1 Conatus Pharmaceuticals
  8.1.1 Company Profile
  8.1.2 Product Picture and Specifications
    8.1.2.1 Type I
    8.1.2.2 Type II
    8.1.2.3 Type III
  8.1.3 Conatus Pharmaceuticals 2015 Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.1.4 Conatus Pharmaceuticals 2015 Non-alcoholic Fatty Liver Disease (NAFLD) Drug Business Region Distribution Analysis
8.2 Daewoong Pharmaceutical
  8.2.1 Company Profile
  8.2.2 Product Picture and Specifications
    8.2.2.1 Type I
    8.2.2.2 Type II
    8.2.2.3 Type III
  8.2.3 Daewoong Pharmaceutical 2015 Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.2.4 Daewoong Pharmaceutical 2015 Non-alcoholic Fatty Liver Disease (NAFLD) Drug Business Region Distribution Analysis
8.3 Galmed International
  8.3.1 Company Profile
  8.3.2 Product Picture and Specifications
    8.3.2.1 Type I
    8.3.2.2 Type II
    8.3.2.3 Type III
  8.3.3 Galmed International 2015 Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.3.4 Galmed International 2015 Non-alcoholic Fatty Liver Disease (NAFLD) Drug Business Region Distribution Analysis
8.4 Kyorin Pharmaceutical
  8.4.1 Company Profile
  8.4.2 Product Picture and Specifications
    8.4.2.1 Type I
    8.4.2.2 Type II
    8.4.2.3 Type III
  8.4.3 Kyorin Pharmaceutical 2015 Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.4.4 Kyorin Pharmaceutical 2015 Non-alcoholic Fatty Liver Disease (NAFLD) Drug Business Region Distribution Analysis
8.5 Metabolic Solutions Development
  8.5.1 Company Profile
  8.5.2 Product Picture and Specifications
    8.5.2.1 Type I
    8.5.2.2 Type II
    8.5.2.3 Type III
  8.5.3 Metabolic Solutions Development 2015 Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.5.4 Metabolic Solutions Development 2015 Non-alcoholic Fatty Liver Disease (NAFLD) Drug Business Region Distribution Analysis
8.6 Novartis AG
  8.6.1 Company Profile
  8.6.2 Product Picture and Specifications
    8.6.2.1 Type I
    8.6.2.2 Type II
    8.6.2.3 Type III
  8.6.3 Novartis AG 2015 Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.6.4 Novartis AG 2015 Non-alcoholic Fatty Liver Disease (NAFLD) Drug Business Region Distribution Analysis
8.7 Phenex Pharmaceuticals
  8.7.1 Company Profile
  8.7.2 Product Picture and Specifications
    8.7.2.1 Type I
    8.7.2.2 Type II
    8.7.2.3 Type III
  8.7.3 Phenex Pharmaceuticals 2015 Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.7.4 Phenex Pharmaceuticals 2015 Non-alcoholic Fatty Liver Disease (NAFLD) Drug Business Region Distribution Analysis
8.8 Raptor Pharmaceuticals
  8.8.1 Company Profile
  8.8.2 Product Picture and Specifications
    8.8.2.1 Type I
    8.8.2.2 Type II
    8.8.2.3 Type III
  8.8.3 Raptor Pharmaceuticals 2015 Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.8.4 Raptor Pharmaceuticals 2015 Non-alcoholic Fatty Liver Disease (NAFLD) Drug Business Region Distribution Analysis
8.9 TCM Biotech International
  8.9.1 Company Profile
  8.9.2 Product Picture and Specifications
    8.9.2.1 Type I
    8.9.2.2 Type II
    8.9.2.3 Type III
  8.9.3 TCM Biotech International 2015 Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.9.4 TCM Biotech International 2015 Non-alcoholic Fatty Liver Disease (NAFLD) Drug Business Region Distribution Analysis
8.10 Tobira Therapeutics
  8.10.1 Company Profile
  8.10.2 Product Picture and Specifications
    8.10.2.1 Type I
    8.10.2.2 Type II
    8.10.2.3 Type III
  8.10.3 Tobira Therapeutics 2015 Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.10.4 Tobira Therapeutics 2015 Non-alcoholic Fatty Liver Disease (NAFLD) Drug Business Region Distribution Analysis
8.11 Verva Pharmaceuticals
  8.11.1 Company Profile
  8.11.2 Product Picture and Specifications
    8.11.2.1 Type I
    8.11.2.2 Type II
    8.11.2.3 Type III
  8.11.3 Verva Pharmaceuticals 2015 Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.11.4 Verva Pharmaceuticals 2015 Non-alcoholic Fatty Liver Disease (NAFLD) Drug Business Region Distribution Analysis
8.12 Zafgen
  8.12.1 Company Profile
  8.12.2 Product Picture and Specifications
    8.12.2.1 Type I
    8.12.2.2 Type II
    8.12.2.3 Type III
  8.12.3 Zafgen 2015 Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.12.4 Zafgen 2015 Non-alcoholic Fatty Liver Disease (NAFLD) Drug Business Region Distribution Analysis

9 DEVELOPMENT TREND OF ANALYSIS OF NON-ALCOHOLIC FATTY LIVER DISEASE (NAFLD) DRUG MARKET

9.1 Global Non-alcoholic Fatty Liver Disease (NAFLD) Drug Market Trend Analysis
  9.1.1 Global 2016-2021 Non-alcoholic Fatty Liver Disease (NAFLD) Drug Market Size (Volume and Value) Forecast
  9.1.2 Global 2016-2021 Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales Price Forecast
9.2 Non-alcoholic Fatty Liver Disease (NAFLD) Drug Regional Market Trend
  9.2.1 North America 2016-2021 Non-alcoholic Fatty Liver Disease (NAFLD) Drug Consumption Forecast
  9.2.2 China 2016-2021 Non-alcoholic Fatty Liver Disease (NAFLD) Drug Consumption Forecast
  9.2.3 Europe 2016-2021 Non-alcoholic Fatty Liver Disease (NAFLD) Drug Consumption Forecast
  9.2.4 Southeast Asia 2016-2021 Non-alcoholic Fatty Liver Disease (NAFLD) Drug Consumption Forecast
  9.2.5 Japan 2016-2021 Non-alcoholic Fatty Liver Disease (NAFLD) Drug Consumption Forecast
  9.2.6 India 2016-2021 Non-alcoholic Fatty Liver Disease (NAFLD) Drug Consumption Forecast
9.3 Non-alcoholic Fatty Liver Disease (NAFLD) Drug Market Trend (Product Type)
9.4 Non-alcoholic Fatty Liver Disease (NAFLD) Drug Market Trend (Application)

10 NON-ALCOHOLIC FATTY LIVER DISEASE (NAFLD) DRUG MARKETING TYPE ANALYSIS

10.1 Non-alcoholic Fatty Liver Disease (NAFLD) Drug Regional Marketing Type Analysis
10.2 Non-alcoholic Fatty Liver Disease (NAFLD) Drug International Trade Type Analysis
10.3 Traders or Distributors with Contact Information of Non-alcoholic Fatty Liver Disease (NAFLD) Drug by Regions
10.4 Non-alcoholic Fatty Liver Disease (NAFLD) Drug Supply Chain Analysis

11 CONSUMERS ANALYSIS OF NON-ALCOHOLIC FATTY LIVER DISEASE (NAFLD) DRUG

11.1 Consumer 1 Analysis
11.2 Consumer 2 Analysis
11.3 Consumer 3 Analysis
11.4 Consumer 4 Analysis

12 CONCLUSION OF THE GLOBAL NON-ALCOHOLIC FATTY LIVER DISEASE (NAFLD) DRUG MARKET PROFESSIONAL SURVEY REPORT 2016

Author List
Table Part of Interviewees Record List
Disclosure Section
Research Methodology
Data Source
China Disclaimer

LIST OF TABLES AND FIGURES

Figure Picture of Non-alcoholic Fatty Liver Disease (NAFLD) Drug
Table Product Specifications of Non-alcoholic Fatty Liver Disease (NAFLD) Drug
Table Classification of Non-alcoholic Fatty Liver Disease (NAFLD) Drug
Figure Global Production Market Share of Non-alcoholic Fatty Liver Disease (NAFLD) Drug by Type in 2015
Table Applications of Non-alcoholic Fatty Liver Disease (NAFLD) Drug
Figure Global Consumption Volume Market Share of Non-alcoholic Fatty Liver Disease (NAFLD) Drug by Application in 2015
Figure Market Share of Non-alcoholic Fatty Liver Disease (NAFLD) Drug by Regions
Figure North America Non-alcoholic Fatty Liver Disease (NAFLD) Drug Market Size (2011-2021)
Figure China Non-alcoholic Fatty Liver Disease (NAFLD) Drug Market Size (2011-2021)
Figure Europe Non-alcoholic Fatty Liver Disease (NAFLD) Drug Market Size (2011-2021)
Figure Southeast Asia Non-alcoholic Fatty Liver Disease (NAFLD) Drug Market Size (2011-2021)
Figure Japan Non-alcoholic Fatty Liver Disease (NAFLD) Drug Market Size (2011-2021)
Figure India Non-alcoholic Fatty Liver Disease (NAFLD) Drug Market Size (2011-2021)
Table Non-alcoholic Fatty Liver Disease (NAFLD) Drug Raw Material and Suppliers
Table Manufacturing Cost Structure Analysis of Non-alcoholic Fatty Liver Disease (NAFLD) Drug in 2015
Figure Manufacturing Process Analysis of Non-alcoholic Fatty Liver Disease (NAFLD) Drug
Figure Industry Chain Structure of Non-alcoholic Fatty Liver Disease (NAFLD) Drug
Table Capacity (Kg) and Commercial Production Date of Global Non-alcoholic Fatty Liver Disease (NAFLD) Drug Major Manufacturers in 2015
Table Manufacturing Plants Distribution of Global Non-alcoholic Fatty Liver Disease (NAFLD) Drug Major Manufacturers in 2015
Table R&D Status and Technology Source of Global Non-alcoholic Fatty Liver Disease (NAFLD) Drug Major Manufacturers in 2015
Table Raw Materials Sources Analysis of Global Non-alcoholic Fatty Liver Disease (NAFLD) Drug Major Manufacturers in 2015
Table Global Capacity (Kg), Sales (Kg), Price (USD/g), Cost (USD/g), Sales Revenue (M USD) and Gross Margin of Non-alcoholic Fatty Liver Disease (NAFLD) Drug 2011-2016
Figure Global 2011-2016E Non-alcoholic Fatty Liver Disease (NAFLD) Drug Market Size (Volume) and Growth Rate
Figure Global 2011-2016E Non-alcoholic Fatty Liver Disease (NAFLD) Drug Market Size (Value) and Growth Rate
Table 2011-2016E Global Non-alcoholic Fatty Liver Disease (NAFLD) Drug Capacity and Growth Rate
Table 2015 Global Non-alcoholic Fatty Liver Disease (NAFLD) Drug Capacity List (Company Segment)
Table 2011-2016E Global Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales and Growth Rate
Table 2015 Global Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales List (Company Segment)
Table 2011-2016E Global Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales Price
Table 2015 Global Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales Price List (Company Segment)
Figure North America Capacity Overview
Table North America Supply, Import, Export and Consumption of Non-alcoholic Fatty Liver Disease (NAFLD) Drug 2011-2016 (Kg)
Figure North America 2011-2016E Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales Price (USD/g)
Figure North America 2015 Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales Market Share
Figure China Capacity Overview
Table China Supply, Import, Export and Consumption of Non-alcoholic Fatty Liver Disease (NAFLD) Drug 2011-2016 (Kg)
Figure China 2011-2016E Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales Price (USD/g)
Figure China 2015 Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales Market Share
Figure Europe Capacity Overview
Table Europe Supply, Import, Export and Consumption of Non-alcoholic Fatty Liver Disease (NAFLD) Drug 2011-2016 (Kg)
Figure Europe 2011-2016E Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales Price (USD/g)
Figure Europe 2015 Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales Market Share
Figure Southeast Asia Capacity Overview
Table Southeast Asia Supply, Import, Export and Consumption of Non-alcoholic Fatty Liver Disease (NAFLD) Drug 2011-2016 (Kg)
Figure Southeast Asia 2011-2016E Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales Price (USD/g)
Figure Southeast Asia 2015 Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales Market Share
Figure Japan Capacity Overview
Table Japan Supply, Import, Export and Consumption of Non-alcoholic Fatty Liver Disease (NAFLD) Drug 2011-2016 (Kg)
Figure Japan 2011-2016E Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales Price (USD/g)
Figure Japan 2015 Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales Market Share
Figure India Capacity Overview
Table India Supply, Import, Export and Consumption of Non-alcoholic Fatty Liver Disease (NAFLD) Drug 2011-2016 (Kg)
Figure India 2011-2016E Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales Price (USD/g)
Figure India 2015 Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales Market Share
Table Global 2011-2016E Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales by Type
Table Different Types Non-alcoholic Fatty Liver Disease (NAFLD) Drug Product Interview Price
Table Global 2011-2016E Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales by Application
Table Different Application Non-alcoholic Fatty Liver Disease (NAFLD) Drug Product Interview Price
Table Conatus Pharmaceuticals Information List
Table Type I Non-alcoholic Fatty Liver Disease (NAFLD) Drug Overview
Table Type II Non-alcoholic Fatty Liver Disease (NAFLD) Drug Overview
Table Type III Non-alcoholic Fatty Liver Disease (NAFLD) Drug Overview
Table 2015 Conatus Pharmaceuticals Non-alcoholic Fatty Liver Disease (NAFLD) Drug Revenue, Sales, Ex-factory Price
Figure 2015 Conatus Pharmaceuticals 2015 Non-alcoholic Fatty Liver Disease (NAFLD) Drug Business Region Distribution
Table Daewoong Pharmaceutical Information List
Table Type I Non-alcoholic Fatty Liver Disease (NAFLD) Drug Overview
Table Type II Non-alcoholic Fatty Liver Disease (NAFLD) Drug Overview
Table Type III Non-alcoholic Fatty Liver Disease (NAFLD) Drug Overview
Table 2015 Daewoong Pharmaceutical Non-alcoholic Fatty Liver Disease (NAFLD) Drug Revenue, Sales, Ex-factory Price
Figure 2015 Daewoong Pharmaceutical 2015 Non-alcoholic Fatty Liver Disease (NAFLD) Drug Business Region Distribution
Table Galmed International Information List
Table Type I Non-alcoholic Fatty Liver Disease (NAFLD) Drug Overview
Table Type II Non-alcoholic Fatty Liver Disease (NAFLD) Drug Overview
Table Type III Non-alcoholic Fatty Liver Disease (NAFLD) Drug Overview
Table 2015 Galmed International Non-alcoholic Fatty Liver Disease (NAFLD) Drug Revenue, Sales, Ex-factory Price
Figure 2015 Galmed International 2015 Non-alcoholic Fatty Liver Disease (NAFLD) Drug Business Region Distribution
Table Kyorin Pharmaceutical Information List
Table Type I Non-alcoholic Fatty Liver Disease (NAFLD) Drug Overview
Table Type II Non-alcoholic Fatty Liver Disease (NAFLD) Drug Overview
Table Type III Non-alcoholic Fatty Liver Disease (NAFLD) Drug Overview
Table 2015 Kyorin Pharmaceutical Non-alcoholic Fatty Liver Disease (NAFLD) Drug Revenue, Sales, Ex-factory Price
Figure 2015 Kyorin Pharmaceutical 2015 Non-alcoholic Fatty Liver Disease (NAFLD) Drug Business Region Distribution
Table Metabolic Solutions Development Information List
Table Type I Non-alcoholic Fatty Liver Disease (NAFLD) Drug Overview
Table Type II Non-alcoholic Fatty Liver Disease (NAFLD) Drug Overview
Table Type III Non-alcoholic Fatty Liver Disease (NAFLD) Drug Overview
Table 2015 Metabolic Solutions Development Non-alcoholic Fatty Liver Disease (NAFLD) Drug Revenue, Sales, Ex-factory Price
Figure 2015 Metabolic Solutions Development 2015 Non-alcoholic Fatty Liver Disease (NAFLD) Drug Business Region Distribution
Table Novartis AG Information List
Table Type I Non-alcoholic Fatty Liver Disease (NAFLD) Drug Overview
Table Type II Non-alcoholic Fatty Liver Disease (NAFLD) Drug Overview
Table Type III Non-alcoholic Fatty Liver Disease (NAFLD) Drug Overview
Table 2015 Novartis AG Non-alcoholic Fatty Liver Disease (NAFLD) Drug Revenue, Sales, Ex-factory Price
Figure 2015 Novartis AG 2015 Non-alcoholic Fatty Liver Disease (NAFLD) Drug Business Region Distribution
Table Phenex Pharmaceuticals Information List
Table Type I Non-alcoholic Fatty Liver Disease (NAFLD) Drug Overview
Table Type II Non-alcoholic Fatty Liver Disease (NAFLD) Drug Overview
Table Type III Non-alcoholic Fatty Liver Disease (NAFLD) Drug Overview
Table 2015 Phenex Pharmaceuticals Non-alcoholic Fatty Liver Disease (NAFLD) Drug Revenue, Sales, Ex-factory Price
Figure 2015 Phenex Pharmaceuticals 2015 Non-alcoholic Fatty Liver Disease (NAFLD) Drug Business Region Distribution
Table Raptor Pharmaceuticals Information List
Table Type I Non-alcoholic Fatty Liver Disease (NAFLD) Drug Overview
Table Type II Non-alcoholic Fatty Liver Disease (NAFLD) Drug Overview
Table Type III Non-alcoholic Fatty Liver Disease (NAFLD) Drug Overview
Table 2015 Raptor Pharmaceuticals Non-alcoholic Fatty Liver Disease (NAFLD) Drug Revenue, Sales, Ex-factory Price
Figure 2015 Raptor Pharmaceuticals 2015 Non-alcoholic Fatty Liver Disease (NAFLD) Drug Business Region Distribution
Table TCM Biotech International Information List
Table Type I Non-alcoholic Fatty Liver Disease (NAFLD) Drug Overview
Table Type II Non-alcoholic Fatty Liver Disease (NAFLD) Drug Overview
Table Type III Non-alcoholic Fatty Liver Disease (NAFLD) Drug Overview
Table 2015 TCM Biotech International Non-alcoholic Fatty Liver Disease (NAFLD) Drug Revenue, Sales, Ex-factory Price
Figure 2015 TCM Biotech International 2015 Non-alcoholic Fatty Liver Disease (NAFLD) Drug Business Region Distribution
Table Tobira Therapeutics Information List
Table Type I Non-alcoholic Fatty Liver Disease (NAFLD) Drug Overview
Table Type II Non-alcoholic Fatty Liver Disease (NAFLD) Drug Overview
Table Type III Non-alcoholic Fatty Liver Disease (NAFLD) Drug Overview
Table 2015 Tobira Therapeutics Non-alcoholic Fatty Liver Disease (NAFLD) Drug Revenue, Sales, Ex-factory Price
Figure 2015 Tobira Therapeutics 2015 Non-alcoholic Fatty Liver Disease (NAFLD) Drug Business Region Distribution
Table Verva Pharmaceuticals Information List
Table Type I Non-alcoholic Fatty Liver Disease (NAFLD) Drug Overview
Table Type II Non-alcoholic Fatty Liver Disease (NAFLD) Drug Overview
Table Type III Non-alcoholic Fatty Liver Disease (NAFLD) Drug Overview
Table 2015 Verva Pharmaceuticals Non-alcoholic Fatty Liver Disease (NAFLD) Drug Revenue, Sales, Ex-factory Price
Figure 2015 Verva Pharmaceuticals 2015 Non-alcoholic Fatty Liver Disease (NAFLD) Drug Business Region Distribution
Table Zafgen Information List
Table Type I Non-alcoholic Fatty Liver Disease (NAFLD) Drug Overview
Table Type II Non-alcoholic Fatty Liver Disease (NAFLD) Drug Overview
Table Type III Non-alcoholic Fatty Liver Disease (NAFLD) Drug Overview
Table 2015 Zafgen Non-alcoholic Fatty Liver Disease (NAFLD) Drug Revenue, Sales, Ex-factory Price
Figure 2015 Zafgen 2015 Non-alcoholic Fatty Liver Disease (NAFLD) Drug Business Region Distribution
Figure Global 2016-2021 Non-alcoholic Fatty Liver Disease (NAFLD) Drug Market Size (Volume) and Growth Rate Forecast
Figure Global 2016-2021 Non-alcoholic Fatty Liver Disease (NAFLD) Drug Market Size (Value) and Growth Rate Forecast
Figure Global 2016-2021 Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales Price (USD/g) Forecast
Figure North America 2016-2021 Non-alcoholic Fatty Liver Disease (NAFLD) Drug Consumption Volume and Growth Rate Forecast
Figure China 2016-2021 Non-alcoholic Fatty Liver Disease (NAFLD) Drug Consumption Volume and Growth Rate Forecast
Figure Europe 2016-2021 Non-alcoholic Fatty Liver Disease (NAFLD) Drug Consumption Volume and Growth Rate Forecast
Figure Southeast Asia 2016-2021 Non-alcoholic Fatty Liver Disease (NAFLD) Drug Consumption Volume and Growth Rate Forecast
Figure Japan 2016-2021 Non-alcoholic Fatty Liver Disease (NAFLD) Drug Consumption Volume and Growth Rate Forecast
Figure India 2016-2021 Non-alcoholic Fatty Liver Disease (NAFLD) Drug Consumption Volume and Growth Rate Forecast
Table Global Sales Volume (Kg) of Non-alcoholic Fatty Liver Disease (NAFLD) Drug by Types 2016-2021
Table Global Consumption Volume (Kg) of Non-alcoholic Fatty Liver Disease (NAFLD) Drug by Applications 2016-2021
Table Traders or Distributors with Contact Information of Non-alcoholic Fatty Liver Disease (NAFLD) Drug by Regions
Table Part of Interviewees Record List

More Publications

Need Help?

Ask a Question

Market Reports

All Categories